Glioma cells overexpressing IDH1-R132H displayed higher chemosensitivity due to increased generation of reactive oxygen species (ROS) and depletion of glutathione, suggesting that they respond better to chemotherapy than IDH1-wt gliomas [127,128]. The gene discussed is IDH1; the disease is central nervous system cancer.